[8-K] FIGS, Inc. Reports Material Event
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
FIGS, Inc. reported strong first quarter 2026 results, with net revenues of $159.9 million, up 28.0% year over year, driven by more orders from both new and existing customers and higher average order value.
Scrubwear net revenues were $126.6 million, while non-scrubwear reached $33.3 million. U.S. net revenues grew 24.1% to $131.6 million, and international net revenues rose 49.9% to $28.3 million.
The company delivered net income of $6.3 million, or $0.03 diluted earnings per share, versus a small loss a year earlier. Net income margin was 3.9%, and adjusted EBITDA was $13.9 million with an 8.7% adjusted EBITDA margin.
Active customers grew 12.2% to 3.0 million, net revenues per active customer rose to $220, and average order value increased to $124. Reflecting this momentum, FIGS raised its full year 2026 outlook, now targeting net revenues growth of 14% to 16% and adjusted EBITDA margin of 13.0% to 13.2%.
Positive
- Strong growth and profitability inflection: Q1 2026 net revenues rose 28.0% to $159.9 million, FIGS shifted from a slight loss to $6.3 million in net income, and expanded adjusted EBITDA margin to 8.7%, then raised full year 2026 revenue and margin guidance.
Negative
- None.
Insights
FIGS posted strong Q1 growth, returned to profit, and raised 2026 guidance.
FIGS delivered Q1 2026 net revenues of $159.9M, up 28.0% year over year, with broad-based strength across scrubwear, non-scrubwear, U.S. and international markets. Active customers reached 3.0 million, and higher average order value pushed net revenues per active customer to $220.
Profitability improved meaningfully. Net income was $6.3M versus a small loss last year, for a 3.9% net income margin. Adjusted EBITDA grew to $13.9M, with margin expanding to 8.7% as operating expenses grew slower than sales, reflecting fixed cost leverage despite higher marketing tied to the 2026 Winter Olympics campaign.
Management increased full year 2026 outlook to net revenues growth of 14%–16% and adjusted EBITDA margin of 13.0%–13.2%, and pointed to low‑20% top-line growth for Q2. While free cash flow was negative $5.6M this quarter, the company ended with $74.3M in cash and $202.7M in short‑term investments, supporting continued investment and shareholder return plans.
8-K Event Classification
3 items: 2.02, 7.01, 9.01
3 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Net revenues: $159.9M
Net income: $6.3M
Adjusted EBITDA: $13.9M
+5 more
8 metrics
Net revenues
$159.9M
Three months ended March 31, 2026; up 28.0% YoY
Net income
$6.3M
Q1 2026 vs $(0.1)M in Q1 2025
Adjusted EBITDA
$13.9M
Q1 2026; adjusted EBITDA margin 8.7%
Net income margin
3.9%
Q1 2026 net income (loss) margin
Free cash flow
-$5.6M
Three months ended March 31, 2026
Active customers
3.0M
3,024 thousand as of March 31, 2026; +12.2% YoY
Average order value
$124
Q1 2026; up from $119 in Q1 2025
2026 revenue growth outlook
14%–16%
Full year 2026 net revenues growth vs 2025
Key Terms
Adjusted EBITDA, Adjusted EBITDA margin, free cash flow, active customers, +2 more
6 terms
Adjusted EBITDA financial
"Adjusted EBITDA(3) was $13.9 million, an increase of $4.7 million year over year."
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Adjusted EBITDA margin financial
"Adjusted EBITDA margin(2)(3) was 8.7%, as compared to 7.3% in the same period last year."
Adjusted EBITDA margin shows how much profit a company makes from its core operations, expressed as a percentage of its total revenue, after removing certain one-time or unusual expenses and income. It helps investors understand the company's true earning ability from regular business activities, making it easier to compare performance over time or with other companies. Think of it as measuring the efficiency of a business in turning sales into profits, excluding irregular adjustments.
free cash flow financial
"The Company uses “free cash flow” as a useful supplemental measure of liquidity and as an additional basis for assessing its ability to generate cash."
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
active customers financial
"Active customers(1) as of March 31, 2026 increased 12.2% year over year to 3.0 million."
Active customers are the count of distinct buyers or users who have engaged with a company’s product or service within a defined recent time frame (for example, the past month or quarter). Investors watch this measure because it shows how many people are actually using the business—similar to counting how many gym members showed up this month—helping assess growth, retention, revenue potential and whether marketing or products are converting interest into real activity.
average order value financial
"AOV(1) was $124, an increase of 4.2% year over year, primarily driven by higher average unit retail due to pricing and favorable product mix."
Average order value (AOV) is the typical amount a customer spends each time they place an order, calculated by dividing total sales by number of orders over a set period. It matters to investors because it shows how efficiently a company turns customer visits into revenue — higher AOV can boost profits without gaining more customers. Think of it like the average bill per table at a restaurant: increasing that bill raises overall sales even if the number of diners stays the same.
Non-GAAP financial measures regulatory
"In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K."
Non-GAAP financial measures are numbers companies use to show their financial performance that exclude certain expenses or income. They help investors see how the company might perform without one-time costs or other unusual items, giving a different perspective from official reports. However, since they can be adjusted, they don’t always tell the full story and should be looked at alongside standard financial figures.
Earnings Snapshot
Net revenues: $159.9M · Guidance included
Q1 2026
Net revenues
$159.9M
+28.0% YoY
Net income
$6.3M
vs $(0.1)M prior-year quarter
Adjusted EBITDA
$13.9M
+$4.7M YoY
Net income margin
3.9%
vs (0.1)% prior-year quarter
Adjusted EBITDA margin
8.7%
vs 7.3% prior-year quarter
Guidance
For full year 2026, FIGS expects net revenues growth of 14% to 16% versus 2025 and adjusted EBITDA margin of 13.0% to 13.2%.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): | ||
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||||||||
Registrant’s Telephone Number, Including Area Code: | ||
2834 Colorado Avenue, Suite 100, Santa Monica, CA 90404 | ||
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 2.02 Results of Operations and Financial Condition.
On May 7, 2026, FIGS, Inc. (the “Company”) announced its financial results for the three months ended March 31, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this “Report”).
Item 7.01 Regulation FD Disclosure.
On May 7, 2026, the Company posted a financial highlights presentation to the “Investor Relations” portion of its website at ir.wearfigs.com/financials/quarterly-results.
The information in Items 2.02 and 7.01 of this Report (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | ||||
| 99.1* | Press Release of the Company, dated May 7, 2026 | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
| * | This exhibit related to Item 2.02 shall be deemed to be furnished, and not filed. | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| FIGS, INC. | |||||||||||
| Date: | May 7, 2026 | By: | /s/ Sarah Oughtred | ||||||||
| Name: | Sarah Oughtred | ||||||||||
| Title: | Chief Financial Officer | ||||||||||
FIGS Releases First Quarter 2026 Financial Results
Exceeded Top and Bottom Line Expectations
Grew Net Revenues 28.0%
Surpassed Three Million Active Customers for the First Time on Accelerated Growth
Achieved Net Income Margin of 3.9% and Adjusted EBITDA Margin of 8.7%
Increasing Full Year 2026 Outlook
SANTA MONICA, Calif., May 7, 2026 — FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its first quarter 2026 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.
First Quarter 2026 Financial Highlights
•Net revenues were $159.9 million, an increase of 28.0% year over year, primarily due to an increase in orders from new and existing customers and higher average order value (“AOV”).(1)
•Scrubwear net revenues were $126.6 million, an increase of 27.2% year over year.
•Non-scrubwear net revenues were $33.3 million, an increase of 31.3% year over year.
•U.S. net revenues were $131.6 million, an increase of 24.1% year over year.
•International net revenues were $28.3 million, an increase of 49.9% year over year.
•Gross margin was 67.7%, an increase of 10 basis points year over year, primarily reflecting the positive impacts from pricing and our ongoing efficiency efforts, largely offset by higher tariffs and product mix shift.
•Operating expenses were $103.8 million, an increase of 22.6% year over year. As a percentage of net revenues, operating expenses decreased to 64.9% from 67.8% in the same period last year, primarily due to fixed cost leverage, lower stock-based compensation expense, and lower fulfillment and shipping expenses, partially offset by higher marketing expenses related to our 2026 Winter Olympics campaign.
•Net income was $6.3 million, or $0.03 in diluted earnings per share, compared to net loss of $(0.1) million, or $(0.00) in diluted earnings per share, in the same period last year.
•Net income (loss) margin(2) was 3.9%, as compared to (0.1)% in the same period last year.
•Adjusted EBITDA(3) was $13.9 million, an increase of $4.7 million year over year.
•Adjusted EBITDA margin(2)(3) was 8.7%, as compared to 7.3% in the same period last year.
“Our outperformance in the first quarter shows that our broad-based momentum from 2025 has continued into 2026,” said Trina Spear, Chief Executive Officer and Co-Founder. “Our excellent top line growth was driven by both acceleration in our active customer base, which surpassed three million for the first time in our history, and strong repeat dynamics. We also paired our top line beat with upside to the bottom line, highlighting the structural advantage of our business model. We believe our product, brand, and community strategies, combined with the substantial long-term tailwinds in healthcare, position us for continued success going forward.”
Key Operating Metrics
•Active customers(1) as of March 31, 2026 increased 12.2% year over year to 3.0 million.
•Net revenues per active customer(1) was $220, an increase of 5.8% year over year.
•AOV(1) was $124, an increase of 4.2% year over year, primarily driven by higher average unit retail due to pricing and favorable product mix.
Full Year 2026 Financial Outlook
Net Revenues growth vs. 2025 | up 14% to 16% | ||||
Adjusted EBITDA Margin(2)(4) | 13.0% to 13.2% | ||||
Sarah Oughtred, Chief Financial Officer, commented, “Our strong start to 2026 fuels our confidence and supports higher net revenues and adjusted EBITDA margin expectations for the rest of the year. We now expect top-line growth of 14% to 16%, including growth in the low 20% range in Q2, driven by strength across active customers, AOV, and frequency. Our improved bottom-line outlook reflects our top-line momentum and operational execution, enabling continued investments in growth while effectively managing higher freight surcharges. Finally, our balance sheet remains a source of strength, positioning us to continue driving shareholder returns.”
(1) “Active customers,” “net revenues per active customer” and “average order value” are key operational and business metrics that are important to understanding the Company’s performance. Please see the sections titled “Non-GAAP Financial Measures and Key Operating Metrics” and “Key Operating Metrics” below for information regarding how the Company calculates its key operational and business metrics and for comparisons of active customers, net revenues per active customer and average order value to the prior year period.
(2) “Net income (loss) margin” and “adjusted EBITDA margin” are calculated by dividing net income (loss) and adjusted EBITDA by net revenues, respectively.
(3) “Adjusted EBITDA” and “adjusted EBITDA margin” are non-GAAP financial measures. Please see the sections titled “Non-GAAP Financial Measures and Key Operating Metrics” and “Reconciliations of GAAP to Non-GAAP Measures” below for more information regarding the Company’s use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.
(4) The Company has not provided a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income outlook because it is unable, without making unreasonable efforts, to project certain reconciling items. These items include, but are not limited to, future stock-based compensation expense, income taxes, expenses related to non-ordinary course disputes, and transaction costs. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company’s control or ability to predict. For more information regarding the Company’s use of non-GAAP financial measures, please see the section titled “Non-GAAP Financial Measures and Key Operating Metrics.”
Conference Call Details
FIGS management will host a conference call and webcast today at 2:00 p.m. PT / 5:00 p.m. ET to discuss the Company’s financial and business results and outlook. To participate, please dial 1-585-542-9983 (US) or 1-833-461-5787 (International) and the conference ID 794176416. The call is also accessible via webcast at ir.wearfigs.com. An archive of the webcast will be available on FIGS’ investor relations website at ir.wearfigs.com until May 7, 2027.
Non-GAAP Financial Measures and Key Operating Metrics
In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. The Company uses “adjusted EBITDA” and “adjusted EBITDA margin” to provide useful supplemental measures that assist in evaluating its ability to generate earnings, provide consistency and comparability with its past financial performance and facilitate period-to-period comparisons of its core operating results as well as the results of its peer companies. The Company uses “free cash flow” as a useful supplemental measure of liquidity and as an additional basis for assessing its ability to generate cash. The Company calculates “adjusted EBITDA” as net income (loss) adjusted to exclude: other income (loss), net; gain/loss on disposal of assets; provision for income taxes; depreciation and amortization expense; stock-based compensation and related expense; transaction costs; and expenses related to non-ordinary course disputes. The Company calculates “adjusted EBITDA margin” by dividing adjusted EBITDA by net revenues. The Company calculates “free cash flow” as net cash (used in) provided by operating activities reduced by capital expenditures, including purchases of property and equipment and capitalized software development costs.
Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included below under the heading “Reconciliations of GAAP to Non-GAAP Measures.”
The Company has also included herein “active customers,” “net revenues per active customer” and “average order value,” which are key operational and business metrics that are important to understanding Company performance. The Company believes the number of active customers is an important indicator of growth as it reflects the reach of the Company’s digital platform, brand awareness and overall value proposition. The Company defines an active customer as a unique customer account that has made at least one purchase in the preceding 12-month period. In any particular period, the Company determines the number of active customers by counting the total number of customers who have made at least one purchase in the preceding 12-month period, measured from the last date of such period. The Company believes measuring net revenues per active customer is important to understanding engagement and retention of customers, and as such, the value proposition for its customer base. The Company defines net revenues per active customer as the sum of total net revenues in the preceding 12-month period divided by the current period active customers. The Company defines average order value as the sum of the total net revenues in a given period divided by the total orders placed in that period. Total orders are the summation of all completed individual purchase transactions in a given period. The Company believes its relatively high average order value demonstrates the premium nature of its products. As the Company expands into and increases its presence in additional product categories, price points and international markets, average order value may fluctuate.
Active customers as of March 31, 2026 and 2025, respectively, net revenues per active customer as of March 31, 2026 and 2025, respectively, and average order value for the three months ended March 31, 2026 and 2025, respectively, are presented below under the heading “Key Operating Metrics.”
About FIGS
FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower, and serve current and future generations of healthcare professionals. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function, and style. We share stories about healthcare professionals’ experiences in ways that inspire them. We build meaningful connections within the healthcare community that we created. Above all, we seek to make an impact for our community, including by advocating for them and always having their backs.
We serve healthcare professionals both in the U.S. and internationally. We also serve healthcare institutions through our TEAMS platform.
Forward Looking Statements
This press release contains various forward-looking statements about the Company within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are based on current management expectations, and which involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, such forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words “anticipate”, “believe”, “contemplate”, “continue”, “could”, “estimate”, “expect”, “forecast”, “future”, “intend”, “may”, “might”, “opportunity”, “outlook”, “plan”, “possible”, “potential”, “predict”, “project,” “should”, “strategy”, “strive”, “target”, “will” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including the Company's belief that its product, brand, and community strategies, combined with the substantial long-term tailwinds in healthcare, position it for continued success; the Company's expectation of top-line growth in the low 20% range in Q2 and the related drivers; the Company's top-line momentum and operational execution; continued investments in growth; higher freight surcharges; the Company's expectation of continuing to drive shareholder returns; and the information under the section titled “Full Year 2026 Financial Outlook,” such as the Company’s outlook as to net revenues growth and adjusted EBITDA margin for the full year ending December 31, 2026; all of which reflect the Company’s expectations based upon currently available information and data. Because such statements are based on expectations as to future financial and operating results and are not
statements of fact, the Company’s actual results, performance or achievements may differ materially from those expressed or implied by the forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements. The following important factors and uncertainties, among others, could cause actual results, performance or achievements to differ materially from those described in these forward-looking statements: the Company’s ability to maintain its historical growth; the Company’s ability to maintain profitability; the Company’s ability to maintain the value and reputation of its brand; the Company’s ability to attract new customers, retain existing customers, and to maintain or increase sales to those customers; the success of the Company’s marketing efforts; the Company’s ability to maintain a strong community of engaged customers and Ambassadors; negative publicity related to the Company’s marketing efforts or use of social media; the Company’s ability to successfully develop and introduce new, innovative and updated products; the competitiveness of the market for healthcare apparel; the Company’s ability to maintain its key employees; the Company’s ability to attract and retain highly skilled team members; risks associated with expansion into, and conducting business in, international markets; changes in, or disruptions to, the Company’s shipping arrangements; the successful operation of the Company’s fulfillment operations; the Company’s ability to accurately forecast customer demand, manage its inventory, and plan for future expenses; the impact of changes in consumer confidence, shopping behavior and consumer spending on demand for the Company’s products; the impact of macroeconomic trends on the Company’s operations; the Company’s reliance on a limited number of third-party suppliers; the impact of global trade policy on the Company’s ability to source and distribute its products; the fluctuating costs of raw materials; the Company’s ability to execute on its B2B growth strategy; the Company’s ability to execute on its retail growth strategy; the Company’s failure to protect proprietary, confidential or sensitive information or personal customer data or risks of cyberattacks; the Company’s failure to protect its intellectual property rights; the fact that the operations of many of the Company’s suppliers and vendors are subject to additional risks that are beyond its control; and other risks, uncertainties and factors discussed in the “Risk Factors” section of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 to be filed with the Securities and Exchange Commission (“SEC”), the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 26, 2026, and the Company’s other periodic filings with the SEC. The forward-looking statements in this press release speak only as of the time made and the Company does not undertake to update or revise them to reflect future events or circumstances.
FIGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
| As of | |||||||||||
| March 31, 2026 | December 31, 2025 | ||||||||||
| Assets | (Unaudited) | ||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | $ | 74,304 | $ | 81,985 | |||||||
| Short-term investments | 202,724 | 218,863 | |||||||||
| Accounts receivable | 5,240 | 6,271 | |||||||||
| Inventory, net | 139,382 | 127,966 | |||||||||
| Prepaid expenses and other current assets | 10,538 | 12,200 | |||||||||
| Total current assets | 432,188 | 447,285 | |||||||||
| Non-current assets | |||||||||||
| Property and equipment, net | 33,144 | 33,938 | |||||||||
| Operating lease right-of-use assets | 56,544 | 57,134 | |||||||||
| Deferred tax assets | 12,181 | 12,187 | |||||||||
| Investment in equity securities | 27,735 | 27,735 | |||||||||
| Other assets | 1,650 | 1,717 | |||||||||
| Total non-current assets | 131,254 | 132,711 | |||||||||
| Total assets | $ | 563,442 | $ | 579,996 | |||||||
| Liabilities and stockholders’ equity | |||||||||||
| Current liabilities | |||||||||||
| Accounts payable | $ | 7,775 | $ | 18,187 | |||||||
| Operating lease liabilities | 8,265 | 8,175 | |||||||||
| Accrued expenses | 35,664 | 20,529 | |||||||||
| Accrued compensation and benefits | 4,853 | 17,194 | |||||||||
| Sales tax payable | 4,927 | 4,266 | |||||||||
| Gift card liability | 11,754 | 12,117 | |||||||||
| Deferred revenue | 1,704 | 3,990 | |||||||||
| Returns reserve | 3,958 | 4,171 | |||||||||
| Income tax payable | 1,303 | 1,894 | |||||||||
| Total current liabilities | 80,203 | 90,523 | |||||||||
| Non-current liabilities | |||||||||||
| Operating lease liabilities, non-current | 52,336 | 51,829 | |||||||||
| Other non-current liabilities | 263 | 182 | |||||||||
| Total liabilities | 132,802 | 142,534 | |||||||||
| Commitments and contingencies | |||||||||||
| Stockholders’ equity | |||||||||||
Class A common stock — par value $0.0001 per share, 1,000,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 158,451,583 and 157,559,556 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 16 | 16 | |||||||||
Class B common stock — par value $0.0001 per share, 150,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 8,283,641 shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — | |||||||||
Preferred stock — par value $0.0001 per share, 100,000,000 shares authorized as of March 31, 2026 and December 31, 2025; zero shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — | |||||||||
| Additional paid-in capital | 325,715 | 338,526 | |||||||||
| Accumulated other comprehensive income (loss) | (103) | 196 | |||||||||
| Retained earnings | 105,012 | 98,724 | |||||||||
| Total stockholders’ equity | 430,640 | 437,462 | |||||||||
| Total liabilities and stockholders’ equity | $ | 563,442 | $ | 579,996 | |||||||
FIGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(Unaudited)
| Three months ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Net revenues | $ | 159,902 | $ | 124,901 | |||||||
| Cost of goods sold | 51,604 | 40,442 | |||||||||
| Gross profit | 108,298 | 84,459 | |||||||||
| Operating expenses | |||||||||||
| Selling | 36,439 | 32,678 | |||||||||
| Marketing | 29,493 | 18,156 | |||||||||
| General and administrative | 37,883 | 33,836 | |||||||||
| Total operating expenses | 103,815 | 84,670 | |||||||||
| Net income (loss) from operations | 4,483 | (211) | |||||||||
| Other income, net | |||||||||||
| Interest income | 2,239 | 2,076 | |||||||||
| Other expense | (277) | (1) | |||||||||
| Total other income, net | 1,962 | 2,075 | |||||||||
| Net income before provision for income taxes | 6,445 | 1,864 | |||||||||
| Provision for income taxes | 157 | 1,966 | |||||||||
| Net income (loss) | $ | 6,288 | $ | (102) | |||||||
| Earnings attributable to Class A and Class B common stockholders | |||||||||||
| Basic earnings (loss) per share | $ | 0.04 | $ | — | |||||||
| Diluted earnings (loss) per share | $ | 0.03 | $ | — | |||||||
| Weighted-average shares outstanding—basic | 166,460,085 | 162,465,988 | |||||||||
| Weighted-average shares outstanding—diluted | 196,090,295 | 162,465,988 | |||||||||
FIGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
| Three months ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income (loss) | $ | 6,288 | $ | (102) | |||||||
| Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: | |||||||||||
| Depreciation and amortization expense | 3,411 | 1,999 | |||||||||
| Deferred income taxes | 6 | 995 | |||||||||
| Non-cash operating lease cost | 2,391 | 2,303 | |||||||||
| Stock-based compensation | 5,451 | 7,239 | |||||||||
| Accretion of discount and accrued interest on available-for-sale securities | (337) | (1,113) | |||||||||
| Realized gains on available-for-sale securities | (32) | — | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable | 1,031 | 2,078 | |||||||||
| Inventory | (11,416) | (15,818) | |||||||||
| Prepaid expenses and other current assets | 1,662 | 2,899 | |||||||||
| Other assets | 67 | 166 | |||||||||
| Accounts payable | (10,600) | 1,303 | |||||||||
| Accrued expenses | 15,130 | 12,406 | |||||||||
| Accrued compensation and benefits | (12,341) | (618) | |||||||||
| Sales tax payable | 661 | 51 | |||||||||
| Gift card liability | (363) | (299) | |||||||||
| Deferred revenue | (2,286) | (2,653) | |||||||||
| Returns reserve | (213) | (172) | |||||||||
| Income tax payable | (591) | 272 | |||||||||
| Operating lease liabilities | (1,204) | (1,701) | |||||||||
| Other non-current liabilities | 81 | — | |||||||||
| Net cash (used in) provided by operating activities | (3,204) | 9,235 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Purchases of property and equipment | (2,424) | (1,310) | |||||||||
| Purchases of available-for-sale securities | (105,452) | (54,624) | |||||||||
| Maturities and sales of available-for-sale securities | 121,676 | 53,951 | |||||||||
| Purchase of investment in equity securities | — | (201) | |||||||||
| Net cash (used in) provided by investing activities | 13,800 | (2,184) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Repurchases of Class A Common Stock | (8,799) | (2,688) | |||||||||
| Proceeds from stock option exercises and employee stock purchases | 295 | — | |||||||||
| Payments for taxes related to net share settlement of equity awards | (9,758) | — | |||||||||
| Net cash used in financing activities | (18,262) | (2,688) | |||||||||
Effect of foreign currency exchange rate changes on cash and cash equivalents | (15) | — | |||||||||
| Net increase (decrease) in cash and cash equivalents | (7,681) | 4,363 | |||||||||
Cash and cash equivalents, beginning of period | $ | 81,985 | $ | 85,645 | |||||||
| Cash and cash equivalents end of period | $ | 74,304 | $ | 90,008 | |||||||
FIGS, INC.
RECONCILIATIONS OF GAAP TO NON-GAAP MEASURES
(Unaudited)
The following table presents a reconciliation of adjusted EBITDA to net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP, and presents adjusted EBITDA margin with net income (loss) margin, which is the most directly comparable financial measure calculated in accordance with GAAP:
| Three months ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| (in thousands) | |||||||||||
| Net income (loss) | $ | 6,288 | $ | (102) | |||||||
| Add (deduct): | |||||||||||
| Other income, net | (1,962) | (2,075) | |||||||||
| Provision for income taxes | 157 | 1,966 | |||||||||
Depreciation and amortization expense(1) | 3,411 | 1,999 | |||||||||
Stock-based compensation and related expense(2) | 5,988 | 7,387 | |||||||||
Adjusted EBITDA(3) | $ | 13,882 | $ | 9,175 | |||||||
| Net Revenues | $ | 159,902 | $ | 124,901 | |||||||
Net income (loss) margin(4) | 3.9 | % | (0.1) | % | |||||||
| Adjusted EBITDA Margin | 8.7 | % | 7.3 | % | |||||||
(1) Excludes amortization of debt issuance costs included in “Other income, net.”
(2) Includes stock-based compensation expense, payroll taxes, and costs related to equity award activity.
(3) For the three months ended March 31, 2025, reflects $171,000 of stock-based compensation expense and payroll taxes inadvertently not reflected in our previously disclosed Adjusted EBITDA results for the same period.
(4) Net income (loss) margin represents net income (loss) as a percentage of net revenues.
The following table presents a reconciliation of free cash flow to net cash (used in) provided by operating activities, which is the most directly comparable financial measure calculated in accordance with GAAP:
| Three months ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| (in thousands) | |||||||||||
| Net cash (used in) provided by operating activities | $ | (3,204) | $ | 9,235 | |||||||
| Less: capital expenditures | (2,424) | (1,310) | |||||||||
| Free cash flow | $ | (5,628) | $ | 7,925 | |||||||
FIGS, INC.
KEY OPERATING METRICS
(Unaudited)
Active customers as of March 31, 2026 and 2025, respectively, net revenues per active customer as of March 31, 2026 and 2025, respectively, and average order value for the three months ended March 31, 2026 and 2025, respectively, are presented in the following tables:
| As of March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| (in thousands) | |||||||||||
| Active customers | 3,024 | 2,696 | |||||||||
| As of March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Net revenues per active customer | $ | 220 | $ | 208 | |||||||
| Three months ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Average order value | $ | 124 | $ | 119 | |||||||
FIGS, INC.
DISAGGREGATED NET REVENUES
(In thousands, except percentages)
(Unaudited)
The following table presents the disaggregation of the Company’s net revenues for the three months ended March 31, 2026 and March 31, 2025:
| Three months ended March 31, | Change | ||||||||||||||||
| 2026 | 2025 | % | |||||||||||||||
| By geography: | |||||||||||||||||
| United States | $ | 131,593 | $ | 106,019 | 24.1 | % | |||||||||||
| Rest of the world | 28,309 | 18,882 | 49.9 | % | |||||||||||||
| $ | 159,902 | $ | 124,901 | 28.0 | % | ||||||||||||
| By product: | |||||||||||||||||
| Scrubwear | $ | 126,643 | $ | 99,569 | 27.2 | % | |||||||||||
| Non-Scrubwear | 33,259 | 25,332 | 31.3 | % | |||||||||||||
| $ | 159,902 | $ | 124,901 | 28.0 | % | ||||||||||||
Contacts
Investors:
Tom Shaw
IR@wearfigs.com
Media:
Todd Maron
press@wearfigs.com